Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024591 (
malignant hyperthermia
)
2,353
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In a report of two patients who died of
malignant hyperthermia
, muscle adenylate kinase deficiency was identified in the father and brother of the deceased. To determine if this
enzyme deficiency
was a biochemical marker for susceptibility to
malignant hyperthermia
, we measured adenylate kinase in muscle of three survivors of
malignant hyperthermia
(MH) and five relatives of survivors of MH attacks with positive caffeine contracture tests. Neither the activity nor the electrophoretic mobility of adenylate kinase differed from four control values. The results show that muscle adenylate kinase deficiency is not a biochemical abnormality shared by all individuals susceptible to
malignant hyperthermia
.
...
PMID:Adenylate kinase deficiency and malignant hyperthermia. 626 42
The activity of carnitine palmitoyl transferase, an enzyme that catalyzes the transport of long-chain acylcarnitines into mitochondria, was quantitated in EB-virus-transformed lymphoblasts from 7 patients with susceptibility for
malignant hyperthermia
. Immunoreactive enzyme protein was also measured using an enzyme-linked immunosorbent assay. Cell lines derived from patients with carnitine palmitoyl transferase deficiency of muscle and from normal individuals were used as positive and negative controls, respectively. One patient with
malignant hyperthermia
had a deficiency in the enzyme activity which was comparable with that of the known carnitine palmitoyl transferase deficient patients. This individual's lymphoblasts were also deficient in immunoreactive enzyme protein. All of the remaining patients with
malignant hyperthermia
were deficient only when the backward assay for carnitine palmitoyl transferase was used for quantitation. It is likely that a subset of individuals with a
malignant hyperthermia
phenotype have a primary deficiency of carnitine palmitoyl transferase and that others have a milder
enzyme deficiency
secondary to the primary defect in
malignant hyperthermia
.
...
PMID:Carnitine palmitoyl transferase deficiency in malignant hyperthermia. 851 56